Androgenetic alopecia (AGA), commonly known as pattern hair loss, is the most prevalent form of hair loss in clinical settings. While corticosteroids and hormonal treatments are widely used, their long-term application is often linked to side effects. As a result, researchers are exploring alternative strategies to manage AGA.
A study published in ACS Pharmacology & Translational Science investigates a cell-free regenerative method using proteins derived from chemically stressed mesenchymal stem cells (MSCs). These proteins—referred to as PDSSCs (Proteins Derived from Stressed Stem Cells)—were obtained by exposing MSCs to an extract from the root of Atalantia monophylla. This botanical agent was used to induce cellular stress, which in turn activated the MSCs to secrete proteins with immunomodulatory and anti-inflammatory properties.
In an AGA mouse model, the administration of PDSSCs led to notable improvements in hair growth. The study reports that these proteins promoted hair follicle regeneration by activating hair follicle stem cells and modulating immune responses. Mechanistically, the beneficial effects were linked to the Wnt and TGF-β signaling pathways, both of which play important roles in tissue repair and hair cycle regulation.
This study is among the first to evaluate the impact of stress-induced MSC secretions in the context of hair follicle regeneration. While the findings are based on preclinical models, they add to the growing body of research investigating non-hormonal, protein-based therapies for conditions like AGA.
